
Agnieszka Boesen
Examiner (ID: 10144, Phone: (571)272-8035 , Office: P/1648 )
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1671, 1672, 1648 |
| Total Applications | 1050 |
| Issued Applications | 614 |
| Pending Applications | 117 |
| Abandoned Applications | 353 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5323472
[patent_doc_number] => 20090061462
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-05
[patent_title] => 'Prion-specific peptide reagents'
[patent_app_type] => utility
[patent_app_number] => 12/079573
[patent_app_country] => US
[patent_app_date] => 2008-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 34655
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20090061462.pdf
[firstpage_image] =>[orig_patent_app_number] => 12079573
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/079573 | Prion-specific peptide reagents | Mar 26, 2008 | Abandoned |
Array
(
[id] => 4960567
[patent_doc_number] => 20080274992
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'RECOMBINANT MODIFIED ANKARA VIRAL HIV-1 VACCINES'
[patent_app_type] => utility
[patent_app_number] => 12/055619
[patent_app_country] => US
[patent_app_date] => 2008-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 18609
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274992.pdf
[firstpage_image] =>[orig_patent_app_number] => 12055619
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/055619 | RECOMBINANT MODIFIED ANKARA VIRAL HIV-1 VACCINES | Mar 25, 2008 | Abandoned |
Array
(
[id] => 4719333
[patent_doc_number] => 20080241855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-02
[patent_title] => 'Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism'
[patent_app_type] => utility
[patent_app_number] => 12/076090
[patent_app_country] => US
[patent_app_date] => 2008-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 17697
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0241/20080241855.pdf
[firstpage_image] =>[orig_patent_app_number] => 12076090
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/076090 | Method for simultaneously detecting an antigen of, and an antibody against, an infectious microorganism | Mar 12, 2008 | Issued |
Array
(
[id] => 6340616
[patent_doc_number] => 20100247618
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'Novel synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV'
[patent_app_type] => utility
[patent_app_number] => 12/073887
[patent_app_country] => US
[patent_app_date] => 2008-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 22515
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247618.pdf
[firstpage_image] =>[orig_patent_app_number] => 12073887
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/073887 | Synthetic peptide vaccines for HIV: the CBD epitope as an effective immunogen to elicit broadly neutralizing antibodies against HIV | Mar 10, 2008 | Issued |
Array
(
[id] => 4927890
[patent_doc_number] => 20080167253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-10
[patent_title] => 'MONOCYTE LOCOMOTION INHIBITORY FACTOR'
[patent_app_type] => utility
[patent_app_number] => 12/040253
[patent_app_country] => US
[patent_app_date] => 2008-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8292
[patent_no_of_claims] => 56
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0167/20080167253.pdf
[firstpage_image] =>[orig_patent_app_number] => 12040253
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/040253 | Monocyte locomotion inhibitory factor | Feb 28, 2008 | Issued |
Array
(
[id] => 6639642
[patent_doc_number] => 20100227313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-09
[patent_title] => 'Methods and Compositions for Determining Altered Susceptibility of HIV-1 to Protease Inhibitor Treatment'
[patent_app_type] => utility
[patent_app_number] => 12/527861
[patent_app_country] => US
[patent_app_date] => 2008-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 28913
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0227/20100227313.pdf
[firstpage_image] =>[orig_patent_app_number] => 12527861
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/527861 | Methods and Compositions for Determining Altered Susceptibility of HIV-1 to Protease Inhibitor Treatment | Feb 24, 2008 | Abandoned |
Array
(
[id] => 4866253
[patent_doc_number] => 20080145312
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-19
[patent_title] => 'Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies'
[patent_app_type] => utility
[patent_app_number] => 12/032397
[patent_app_country] => US
[patent_app_date] => 2008-02-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2532
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0145/20080145312.pdf
[firstpage_image] =>[orig_patent_app_number] => 12032397
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/032397 | Methods for rapid screening of mad cow disease and other transmissible spongiform encephalopathies | Feb 14, 2008 | Abandoned |
Array
(
[id] => 10115772
[patent_doc_number] => 09150643
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-10-06
[patent_title] => 'Methods for treating diabetes'
[patent_app_type] => utility
[patent_app_number] => 12/070067
[patent_app_country] => US
[patent_app_date] => 2008-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 15
[patent_no_of_words] => 11931
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12070067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/070067 | Methods for treating diabetes | Feb 13, 2008 | Issued |
Array
(
[id] => 5507986
[patent_doc_number] => 20090081193
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-03-26
[patent_title] => 'HEMAGGLUTININ POLYPEPTIDES, AND REAGENTS AND METHODS RELATING THERETO'
[patent_app_type] => utility
[patent_app_number] => 11/969040
[patent_app_country] => US
[patent_app_date] => 2008-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 38
[patent_no_of_words] => 27586
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20090081193.pdf
[firstpage_image] =>[orig_patent_app_number] => 11969040
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/969040 | HEMAGGLUTININ POLYPEPTIDES, AND REAGENTS AND METHODS RELATING THERETO | Jan 2, 2008 | Abandoned |
Array
(
[id] => 4825802
[patent_doc_number] => 20080124793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-29
[patent_title] => 'MEMBRANE FUSION PROTEINS DERIVED FROM REOVIRUS'
[patent_app_type] => utility
[patent_app_number] => 11/952714
[patent_app_country] => US
[patent_app_date] => 2007-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13682
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20080124793.pdf
[firstpage_image] =>[orig_patent_app_number] => 11952714
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/952714 | Membrane fusion proteins derived from reovirus | Dec 6, 2007 | Issued |
Array
(
[id] => 4859146
[patent_doc_number] => 20080267996
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'Compositions for inducing an immune response against hepatitis B'
[patent_app_type] => utility
[patent_app_number] => 11/986294
[patent_app_country] => US
[patent_app_date] => 2007-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 19210
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0267/20080267996.pdf
[firstpage_image] =>[orig_patent_app_number] => 11986294
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/986294 | Compositions for inducing an immune response against hepatitis B | Nov 19, 2007 | Abandoned |
Array
(
[id] => 8189603
[patent_doc_number] => 08183354
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-05-22
[patent_title] => 'Virus coat protein/receptor chimeras and methods of use'
[patent_app_type] => utility
[patent_app_number] => 11/940445
[patent_app_country] => US
[patent_app_date] => 2007-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 15
[patent_no_of_words] => 19940
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 140
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/183/08183354.pdf
[firstpage_image] =>[orig_patent_app_number] => 11940445
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/940445 | Virus coat protein/receptor chimeras and methods of use | Nov 14, 2007 | Issued |
Array
(
[id] => 581119
[patent_doc_number] => 07449323
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-11-11
[patent_title] => 'Hemorrhagic feline calicivirus'
[patent_app_type] => utility
[patent_app_number] => 11/939480
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8301
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/449/07449323.pdf
[firstpage_image] =>[orig_patent_app_number] => 11939480
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/939480 | Hemorrhagic feline calicivirus | Nov 12, 2007 | Issued |
Array
(
[id] => 4833367
[patent_doc_number] => 20080131914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'ASSESSING RISK OF CEREBROVASCULAR THROMBOSIS BY MEASURING C4D'
[patent_app_type] => utility
[patent_app_number] => 11/939188
[patent_app_country] => US
[patent_app_date] => 2007-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7625
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0131/20080131914.pdf
[firstpage_image] =>[orig_patent_app_number] => 11939188
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/939188 | ASSESSING RISK OF CEREBROVASCULAR THROMBOSIS BY MEASURING C4D | Nov 12, 2007 | Abandoned |
Array
(
[id] => 24377
[patent_doc_number] => 07795417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-09-14
[patent_title] => 'Oligonucleotides and methods for detection of west nile virus'
[patent_app_type] => utility
[patent_app_number] => 11/935668
[patent_app_country] => US
[patent_app_date] => 2007-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 1
[patent_no_of_words] => 10779
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/795/07795417.pdf
[firstpage_image] =>[orig_patent_app_number] => 11935668
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/935668 | Oligonucleotides and methods for detection of west nile virus | Nov 5, 2007 | Issued |
Array
(
[id] => 11205381
[patent_doc_number] => 09435001
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-09-06
[patent_title] => 'Detection method for cervical HPVS'
[patent_app_type] => utility
[patent_app_number] => 12/741018
[patent_app_country] => US
[patent_app_date] => 2007-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7104
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 261
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12741018
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/741018 | Detection method for cervical HPVS | Oct 31, 2007 | Issued |
Array
(
[id] => 5574978
[patent_doc_number] => 20090142339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-06-04
[patent_title] => 'Humanized Anti-CCR2 Antibodies and Methods of Use Therefor'
[patent_app_type] => utility
[patent_app_number] => 11/924783
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 33503
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0142/20090142339.pdf
[firstpage_image] =>[orig_patent_app_number] => 11924783
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/924783 | Humanized Anti-CCR2 Antibodies and Methods of Use Therefor | Oct 25, 2007 | Abandoned |
Array
(
[id] => 5434955
[patent_doc_number] => 20090169541
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-07-02
[patent_title] => 'Humanized Anti-CCR2 Antibodies and Methods of Use Therefor'
[patent_app_type] => utility
[patent_app_number] => 11/925080
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 39
[patent_no_of_words] => 33503
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0169/20090169541.pdf
[firstpage_image] =>[orig_patent_app_number] => 11925080
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/925080 | Humanized Anti-CCR2 Antibodies and Methods of Use Therefor | Oct 25, 2007 | Abandoned |
Array
(
[id] => 266926
[patent_doc_number] => 07566450
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2009-07-28
[patent_title] => 'Humanized anti-CCR2 antibodies and methods of use therefor'
[patent_app_type] => utility
[patent_app_number] => 11/924794
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 39
[patent_figures_cnt] => 64
[patent_no_of_words] => 33550
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/566/07566450.pdf
[firstpage_image] =>[orig_patent_app_number] => 11924794
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/924794 | Humanized anti-CCR2 antibodies and methods of use therefor | Oct 25, 2007 | Issued |
Array
(
[id] => 6562180
[patent_doc_number] => 20100272753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'Recombinant Adenovirus Vaccines'
[patent_app_type] => utility
[patent_app_number] => 12/447357
[patent_app_country] => US
[patent_app_date] => 2007-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 9073
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20100272753.pdf
[firstpage_image] =>[orig_patent_app_number] => 12447357
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/447357 | Recombinant Adenovirus Vaccines | Oct 25, 2007 | Abandoned |